Tag Archives: INTA

Bioinnovo will increase production of the vaccine against Bovine Viral Diarrhea Virus

Bioinnovo, a public-private partnership between INTA and Vetanco S.A., will allocate an important support, granted by the Ministry [...]

A new achievement in the fight against COVID-19

A multidisciplinary team, where Bioinnovo SA participates, developed IgY avian antibodies that neutralize the COVID-19 [...]

Vetanco and Bioinnovo congratulate the company Algenex on a new achievement

Algenex, the Spanish company delivering recombinant technologies, a key factor for the development of Vedevax BLOCK, [...]

Bovine Viral Diarrhea: the Argentinian vaccine will be sold in Peru

The Andean Country authorized the commercialization of Vedevax Block, the first recombinant vaccine for the control [...]

Vetanco develops an alliance with the UDESC

The constant Research and Development is a principle of Vetanco DNA and the reason why [...]

Bioinnovo inoculated the first batch of birds with RBD (Receptor-Binding Domain) protein of SARS-CoV-2 to develop IgY for a possible use in treatment and diagnosis

Bioinnovo, the public-private company (INTA–Vetanco) made its first contribution to the macro collaborative project conducted [...]

MIT -Massachusetts Institute of Technology – experts visited Vetanco

Following the signing of a Memorandum of Understanding/Cooperation Agreement (MOU) between the MIT startup Sunflower and Bioinnovo, Kerry Love, PhD [...]

Bioinnovo, Algenex reinforce vaccine molecule Arrangement

Argentina’s Bioinnovo has updated its partnership with Spanish firm Algenex for the use of a [...]

Bioinnovo and Algenex renew agreement for the use of APCH

Bioinnovo, the technology-based public-private company formed by the National Institute of Agricultural Technology (INTA) and [...]

Argentine Company looks to license a vaccine developed by researchers of Universidad de Concepcion, Chile

Representatives of Vetanco met with university authorities to discuss a license contract for a recombinant [...]